12988 Valley View Road
Eden Prairie, MN 55344
United States
952 345 4200
https://www.nuwellis.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 70
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Nestor Jaramillo Jr. | Pres, CEO & Director | 502.82k | N/A | 1957 |
Mr. Neil P. Ayotte Esq. | Sr. VP, Gen. Counsel, Sec. & Chief Compliance Officer | 223.89k | N/A | 1964 |
Ms. Lynn L. Blake CPA, M.B.A. | Chief Financial Officer | N/A | N/A | 1967 |
Mr. Rob Scott | Sr. Director of Financial Planning & Analysis and Interim Principal Accounting Officer | N/A | N/A | N/A |
Mr. John Kowalczyk | VP of Sales | N/A | N/A | N/A |
Ms. Sandra Eayrs | Chief HR Officer | N/A | N/A | N/A |
Mr. Vitaliy Epshteyn | Sr. VP of Operations & Engineering | N/A | N/A | 1978 |
Dr. John Lynn Jefferies FACC, M.D., M.P.H. | Chief Medical Officer & Member of Medical Advisory Board | N/A | N/A | N/A |
Mr. Paul Wotta | Corp. Controller | N/A | N/A | 1957 |
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Nuwellis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.